Processo sobre a "segurança" da pílula do aborto: atualização sobre a mifepristona
Esta atualização trata do questionamento judicial sobre a segurança da mifepristona, medicamento usado no aborto. O apresentador argumenta que não-especialistas em medicina não deveriam avaliar a segurança desse remédio, que ele descreve como amplamente comprovado. O vídeo também reúne links para documentos judiciais, reportagens e fontes médicas e de pesquisa sobre a segurança e a regulamentação do medicamento.
Neste vídeo- Atualização sobre o questionamento judicial da segurança da mifepristona
- A visão do apresentador sobre o histórico de segurança do medicamento
- Links para documentos judiciais, notícias e fontes médicas
The mifepristone (abortion medication) legal case continues to be asinine propaganda bullsh*t. It was propaganda nonsense when it was originally filed and it still is, because in what world should a bunch of non-medical experts be allowed to review the safety of a medication that’s been proven TIME AND TIME AGAIN to be EXTREMELY SAFE?! Safer than literal Tylenol. It makes me so angry and the only way to vent that anger is to tell you all about it, so here it is: an update on the mifepristone lawsuit. Watch next: First Mifepristone Case Video: https://youtu.be/0iVEHcS_kGs?si=mnuxgx-WGL5U68ii Emergency Contraception: https://youtu.be/nj4N92c6Uxo?si=USv0fbbDfBtk5J2I What Your Doctor Needs You To Know About Abortion Pills: https://youtu.be/q6NHEukAnNI?si=jd2sLg47pVwpQbA3 References: MSNBC mifepristone update: https://youtu.be/ESTLS4pTkGs?si=s5caqE2CTdGSibfo Filing: https://www.law360.com/cases/6377d1beb6593203c70c9b44 Washington Post - overview of the TX case: https://www.washingtonpost.com/national-security/2023/03/15/texas-judge-abortion-pill-mifepristone-fda/ NYTimes - additional coverage of the TX case: https://www.nytimes.com/2023/03/15/health/abortion-pills-texas-lawsuit.html AG vs FDA to Remove REMS Restrictions: https://agportal-s3bucket.s3.amazonaws.com/uploadedfiles/Another/News/Press_Releases/Mifepristone%20Complaint.pdf ACOG Push Back to ADF: https://www.acog.org/news/news-releases/2023/02/acog-leads-amicus-brief-calling-mifepristone-conclusively-safe-and-effective ACOG REMS Input: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2023/01/updated-mifepristone-rems-requirements 2017 NEJM Article for Removal from REMS: https://sci-hub.se/10.1056/NEJMsb1612526 Mifepristone Safety Overview from ANSIRH: https://www.ansirh.org/sites/default/files/2022-11/mifepristone_safety_11-15-22_Updated_0.pdf Mifepristone Post-Marketing Data: https://www.fda.gov/media/154941/download Comparative Safety Legal Abortion vs Pregnancy: https://journals.lww.com/greenjournal/Abstract/2012/02000/The_Comparative_Safety_of_Legal_Induced_Abortion.3.aspx Comstock Application (DOJ Slip Opinion): https://www.justice.gov/olc/opinion/file/1560596/download NBC - Judge Kacsmaryk seems sympathetic to anti-choice arguments: https://www.nbcnews.com/news/us-news/abortion-pill-case-texas-judge-appears-sympathetic-challenge-rcna75069 New York Times - Wyoming governor signs ban on abortion pills: https://www.nytimes.com/2023/03/17/us/wyoming-abortion-pills-ban.html 12 States Challenge Restrictions on Mifepristone: https://www.reuters.com/legal/democratic-led-us-states-sue-challenge-federal-restrictions-abortion-pill-2023-02-24/ JAMA Viagra: https://jamanetwork.com/journals/jama/article-abstract/1843222 SPLC Categorizes ADF as Extremist Hate Group: https://www.splcenter.org/fighting-hate/extremist-files/group/alliance-defending-freedom Alliance Defending Freedom info: ADF Adoption Case: https://www.nytimes.com/2022/01/22/us/tennessee-jewish-couple-adopt
Mama Doctor Jones
- Site de origem
- youtube.com
- Página original
- https://www.youtube.com/watch?v=hhbDwhKNquY
- Plataforma de vídeo
- YouTube
- Publicado na fonte
- 9 de outubro de 2023 às 17:00
- Duração
- 11:49
- Publicado na fonte9 de outubro de 2023 às 17:00
- Encontrado pelo searchvideo17 de outubro de 2026 às 10:11
- Verificação de duplicados concluída
- Publicado no site17 de outubro de 2026 às 10:12
Comentários
Ainda não há comentários. Seja o primeiro a escrever um!